Even if you don’t work specifically in oncology, chances are you’ll encounter patients with cancer in your practice-which means you may also run into mucositis. So whether you’re aiming for that PGY2 in oncology or to be your town’s favorite community practitioner, come learn what medications we use to prevent and treat this consequence of chemotherapy.
Read MoreWe talk a lot on tl;dr about what medications to add for patients. But is there a point at which all the prescriptions tip the scales and become too much? Is there such a thing?
Read MoreWe’ve covered several cardiology topics over the years in previous posts, including heart failure and LVADs, but we (and our guest posters) never quite mustered the courage to tackle Acute Coronary Syndrome. Until today. Today we bring you the tl;dr overview of ACS!
Read MoreIt’s finally almost time… This day holds more anticipation than William and Kate’s wedding! (Seriously.) It’s almost Match Day. So what happens if your plans collapse and you don’t Match?
Read MoreWe’ve previously given you our best tips for passing the NAPLEX on your first try. We even have a post specifically about the California pharmacy law exam. But what we haven’t tackled yet is formulating all our collective knowledge into one post about how to pass any MPJE on the first try. Well, tl;dr friends, today is the day.
Read MoreEver been totally immersed in the methods section of a study paper and wondered, “Why are there so many endpoints? What does it all MEAN?!” Yeah, us too. Which is why we’re going to try to make this essential part of trial endpoint evaluation just a smidge more clear for you.
Read MoreWith new drugs entering the market all the time and drug prices rapidly increasing, we have to ask the tough question - is the drug worth the cost? Although this question is rarely easy or straightforward to answer, we do have tools available to us to shed some light. Let tl;dr introduce you to the world of pharmacoeconomics!
Read MoreChildren are just tiny humans, right? Munchkins who function identically to adults, just on a smaller scale? NOT! Today we’re introducing you to a couple reasons why this isn’t true and then reviewing management of several classic pediatric illnesses.
Read MoreThe p-value and power are the holy grails of statistical significance, right? Let’s make sure you understand them (and how they can be exploited). This article may blow your mind. Journal club just got a whole lot more interesting…
Read MoreFirst there were regular insulins, then intermediate-acting NPH insulins, then long-acting, and most recently ultra long-acting, which is actually still a daily product. So what’s this about a possible once-weekly insulin? Wouldn’t that blow the other so-called long-acting products out of the water? Perhaps it’s time to judge with journal club.
Read MoreWe spend 4+ years as pharmacists getting our bearings for managing human pharmacotherapy. So what happens when your patient is no longer human? Are there medications on your shelves right now that you might be able to use for your humans’ furry family members?
Read MoreUTIs are one of the most common infections you’ll encounter in both the inpatient and the outpatient world. There have been several new drugs approved in the last few years, and there has been a push towards shorter treatment durations. Get yourself caught up to speed with the latest and greatest in UTI treatment.
Read More
